See more : Linc AB (LINC.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Clean Science and Technology Limited (CLEAN.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clean Science and Technology Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Qiansui International Group Co. Ltd. (QIAN) Income Statement Analysis – Financial Results
- Alumis Inc. Common Stock (ALMS) Income Statement Analysis – Financial Results
- Duni AB (publ) (0HR3.L) Income Statement Analysis – Financial Results
- Skyworth Digital Co., Ltd. (000810.SZ) Income Statement Analysis – Financial Results
- BAB, Inc. (BABB) Income Statement Analysis – Financial Results
Clean Science and Technology Limited (CLEAN.NS)
About Clean Science and Technology Limited
Clean Science and Technology Limited engages in the research, development, manufacture, and marketing of specialty chemicals in India and internationally. The company offers anisole, mono methyl ether of hydroquinone, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, N,N'-dicyclohexylcarbodiimide, tertiary butyl hydroquinone, para benzoquinone, 2,5-di-tertiary butyl hydroquinone, and para di-methoxy benzene (1,4-DMB). It serves consumer and industrial markets. The company was incorporated in 2003 and is based in Pune, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.80B | 9.36B | 6.78B | 5.07B | 4.09B | 3.85B | 2.35B |
| Cost of Revenue | 3.50B | 3.26B | 2.26B | 1.24B | 1.30B | 1.72B | 1.66B |
| Gross Profit | 4.29B | 6.10B | 4.52B | 3.83B | 2.79B | 2.13B | 692.04M |
| Gross Profit Ratio | 55.06% | 65.17% | 66.66% | 75.46% | 68.24% | 55.24% | 29.43% |
| Research & Development | 0.00 | 29.83M | 73.37M | 23.29M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 487.50M | 59.38M | 50.83M | 40.31M | 25.83M | 16.88M | 160.09M |
| Selling & Marketing | 1.46M | 205.07M | 129.45M | 123.28M | 80.80M | 46.75M | 2.74M |
| SG&A | 488.96M | 264.45M | 180.28M | 163.59M | 106.63M | 63.63M | 81.08M |
| Other Expenses | 0.00 | 298.25M | 15.41M | 3.15M | 2.10M | 3.16M | -2.69M |
| Operating Expenses | 488.96M | 2.44B | 1.76B | 1.40B | 1.07B | 868.58M | 83.77M |
| Cost & Expenses | 3.99B | 5.70B | 4.02B | 2.65B | 2.37B | 2.59B | 1.74B |
| Interest Income | 28.84M | 60.34M | 60.90M | 29.45M | 1.36M | 870.00K | 6.46M |
| Interest Expense | 12.74M | 1.95M | 1.47M | 910.00K | 1.21M | 330.00K | 0.00 |
| Depreciation & Amortization | 459.25M | 360.90M | 249.18M | 172.05M | 137.14M | 110.33M | 75.95M |
| EBITDA | 3.74B | 4.32B | 3.30B | 2.85B | 1.96B | 1.48B | 733.18M |
| EBITDA Ratio | 47.92% | 46.16% | 47.46% | 54.61% | 46.58% | 38.20% | 29.09% |
| Operating Income | 3.92B | 3.66B | 2.75B | 2.42B | 1.72B | 1.25B | 608.27M |
| Operating Income Ratio | 50.29% | 39.12% | 40.58% | 47.75% | 41.91% | 32.59% | 25.86% |
| Total Other Income/Expenses | -656.65M | -689.04M | -1.08B | -656.14M | 104.53M | 108.29M | -370.32M |
| Income Before Tax | 3.27B | 3.96B | 3.05B | 2.67B | 1.82B | 1.37B | 702.51M |
| Income Before Tax Ratio | 41.87% | 42.28% | 44.99% | 52.73% | 44.54% | 35.48% | 29.87% |
| Income Tax Expense | 824.74M | 1.00B | 763.01M | 689.21M | 426.85M | 388.78M | 213.53M |
| Net Income | 2.44B | 2.95B | 2.28B | 1.98B | 1.40B | 976.58M | 488.98M |
| Net Income Ratio | 31.29% | 31.54% | 33.72% | 39.13% | 34.11% | 25.38% | 20.79% |
| EPS | 22.97 | 27.79 | 21.51 | 18.68 | 13.15 | 9.19 | 4.60 |
| EPS Diluted | 22.96 | 27.78 | 21.51 | 18.68 | 13.15 | 9.19 | 4.60 |
| Weighted Avg Shares Out | 106.25M | 106.23M | 106.22M | 106.22M | 106.22M | 106.22M | 106.22M |
| Weighted Avg Shares Out (Dil) | 106.27M | 106.26M | 106.25M | 106.22M | 106.22M | 106.22M | 106.22M |
Source: https://incomestatements.info
Category: Stock Reports